Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

C Criscitiello, HA Azim Jr, D Adbor-tarh, E de Azambuja, M Piccart, J Baselga, H Eidtmann, S Di Cosimo, Ian Bradbury, IT Rubio

    Research output: Contribution to journalArticle

    20 Citations (Scopus)
    LanguageEnglish
    Pages1980-1985
    JournalAnnals of Oncology
    Volume24
    Issue number8
    DOIs
    Publication statusPublished - 2013

    Cite this

    Criscitiello, C ; Azim Jr, HA ; Adbor-tarh, D ; de Azambuja, E ; Piccart, M ; Baselga, J ; Eidtmann, H ; Di Cosimo, S ; Bradbury, Ian ; Rubio, IT. / Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. In: Annals of Oncology. 2013 ; Vol. 24, No. 8. pp. 1980-1985.
    @article{9f1c8e7f0f424da696fcb7215b2b6290,
    title = "Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial",
    author = "C Criscitiello and {Azim Jr}, HA and D Adbor-tarh and {de Azambuja}, E and M Piccart and J Baselga and H Eidtmann and {Di Cosimo}, S and Ian Bradbury and IT Rubio",
    year = "2013",
    doi = "10.1093/annonc/mdt129",
    language = "English",
    volume = "24",
    pages = "1980--1985",
    journal = "Annals of Oncology",
    issn = "0923-7534",
    number = "8",

    }

    Criscitiello, C, Azim Jr, HA, Adbor-tarh, D, de Azambuja, E, Piccart, M, Baselga, J, Eidtmann, H, Di Cosimo, S, Bradbury, I & Rubio, IT 2013, 'Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial', Annals of Oncology, vol. 24, no. 8, pp. 1980-1985. https://doi.org/10.1093/annonc/mdt129

    Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial. / Criscitiello, C; Azim Jr, HA; Adbor-tarh, D; de Azambuja, E; Piccart, M; Baselga, J; Eidtmann, H; Di Cosimo, S; Bradbury, Ian; Rubio, IT.

    In: Annals of Oncology, Vol. 24, No. 8, 2013, p. 1980-1985.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Factors associated with surgical management following neoadjuvant therapy in patients with primary HER2-positive breast cancer: results from the NeoALTTO phase III trial

    AU - Criscitiello, C

    AU - Azim Jr, HA

    AU - Adbor-tarh, D

    AU - de Azambuja, E

    AU - Piccart, M

    AU - Baselga, J

    AU - Eidtmann, H

    AU - Di Cosimo, S

    AU - Bradbury, Ian

    AU - Rubio, IT

    PY - 2013

    Y1 - 2013

    U2 - 10.1093/annonc/mdt129

    DO - 10.1093/annonc/mdt129

    M3 - Article

    VL - 24

    SP - 1980

    EP - 1985

    JO - Annals of Oncology

    T2 - Annals of Oncology

    JF - Annals of Oncology

    SN - 0923-7534

    IS - 8

    ER -